Denmark at a glance
- Population
- 6.0 million 2025
- Life expectancy at birth
- 82.3 years, 2024
- People aged 65 and over
- 21.1 % of people, 2025
- Health spending per person
- 6,745 US$ per person, 2024
- Doctors
- 4.50 per 1,000 people, 2021
Updated
Reviewed by Chandani Patel
Denmark Cardiovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$212.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $303.1 Mn | — | — |
| 2025 (base) | $320.7 Mn | +$17.6 Mn | — |
| 2026 (forecast) | $339.3 Mn | +$18.6 Mn | +5.8% |
| 2027 (forecast) | $359.0 Mn | +$19.7 Mn | +11.9% |
| 2028 (forecast) | $379.8 Mn | +$20.8 Mn | +18.4% |
| 2029 (forecast) | $401.8 Mn | +$22.0 Mn | +25.3% |
| 2030 (forecast) | $425.1 Mn | +$23.3 Mn | +32.6% |
| 2031 (forecast) | $449.8 Mn | +$24.7 Mn | +40.3% |
| 2032 (forecast) | $475.9 Mn | +$26.1 Mn | +48.4% |
| 2033 (forecast) | $503.5 Mn | +$27.6 Mn | +57% |
| 2034 (forecast) | $532.7 Mn | +$29.2 Mn | +66.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $320.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $532.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Johnson & Johnson and 1 more (see all) |
| Regulator in Denmark | Danish Medicines AgencySource: Danish Medicines Agency. Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cardiovascular devices diagnose, monitor and treat heart and blood vessel disease, from stents and valves to pacemakers.
Key segments of the cardiovascular devices market include product (Stents, Heart Valves and Pacemakers and Defibrillators) and application (Coronary Artery Disease, Arrhythmia and Heart Failure).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the cardiovascular devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the cardiovascular devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the cardiovascular devices market.
The cardiovascular devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need CE marking under the EU Medical Device Regulation (MDR); in Denmark, the Danish Medicines Agency oversees them.[1] Tax-funded public health care is free for residents and run by the regions; the Danish Medicines Agency decides which medicines get general reimbursement.[1]
[1] Danish Medicines Agency. Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cardiovascular devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Denmark.
What doctors and scientists are doing in Cardiovascular Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Digital Health · Global
Pharmaceuticals · Global
Pharmaceuticals · Global
Pharmaceuticals · Global
Pharmaceuticals · Global
Healthcare Services · Global